Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

Abstract

The multi-biomarker disease activity (MBDA) score measures 12 proteins involved in the pathophysiology of rheumatoid arthritis (RA) to assess disease activity (DA). Previous studies demonstrated correlations between MBDA and clinical DA scores with some RA therapies. In this analysis, the relationship between DA and MBDA scores and changes in MBDA component… (More)
DOI: 10.1007/s00296-015-3285-2

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Reiss2015InterpretingTM, title={Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis}, author={William G. Reiss and Jenny Devenport and Jason M. Low and George Wu and Eric H. Sasso}, booktitle={Rheumatology International}, year={2015} }